Profile
Sigurd Okkels is the founder of two companies, Profound Pharma AS and Maxygen ApS, both founded in 1999.
At Profound Pharma AS, he held the title of Director-Science & Technology from 1999 to 2005.
At Maxygen ApS, he also held the title of Director-Science & Technology from 1999 to 2005.
Dr. Okkels's former jobs include Vice President at Takeda Pharmaceutical Co., Ltd.
from 2011 to 2017, Vice President-Technology at.
Takeda A from 2009 to 2011, and Senior Vice President-Product Development at Ascendis Pharma A from 2019 to 2023.
Dr. Okkels received a graduate degree and a doctorate from the University of Copenhagen.
Former positions of Sigurd Okkels
Companies | Position | End |
---|---|---|
ASCENDIS PHARMA A/S | Corporate Officer/Principal | 2023-09-29 |
TAKEDA PHARMACEUTICAL COMPANY LIMITED | Corporate Officer/Principal | 2017-11-30 |
Takeda A/S
Takeda A/S Financial ConglomeratesFinance Takeda A/S engages in holding or owning of securities in other companies other than banks. The company was founded on January 4, 2005 and is headquartered in Taastrup, Denmark. | Chief Tech/Sci/R&D Officer | 2011-09-30 |
Maxygen ApS | Founder | 2005-04-30 |
Profound Pharma AS
Profound Pharma AS Pharmaceuticals: MajorHealth Technology Profound Pharma AS provides pharmaceutical products. The Danish company was founded by Jan Møller Mikkelsen, Anders H. Pedersen, Hans Thalsgård Schambye. Profound Pharma was acquired by Maxygen, Inc. on August 10, 2000 for $69.46 million. | Founder | 2004-12-31 |
Training of Sigurd Okkels
University of Copenhagen | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 2 |
---|---|
TAKEDA PHARMACEUTICAL COMPANY LIMITED | Health Technology |
ASCENDIS PHARMA A/S | Health Technology |
Private companies | 3 |
---|---|
Profound Pharma AS
Profound Pharma AS Pharmaceuticals: MajorHealth Technology Profound Pharma AS provides pharmaceutical products. The Danish company was founded by Jan Møller Mikkelsen, Anders H. Pedersen, Hans Thalsgård Schambye. Profound Pharma was acquired by Maxygen, Inc. on August 10, 2000 for $69.46 million. | Health Technology |
Takeda A/S
Takeda A/S Financial ConglomeratesFinance Takeda A/S engages in holding or owning of securities in other companies other than banks. The company was founded on January 4, 2005 and is headquartered in Taastrup, Denmark. | Finance |
Maxygen ApS |
- Stock Market
- Insiders
- Sigurd Okkels